N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-alanine丨CAS 35661-39-3

N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-alanine丨CAS 35661-39-3, is a fluorenylmethoxycarbonyl (Fmoc)-protected amino acid derivative. It is widely used in peptide synthesis and is a key component in solid-phase peptide synthesis (SPPS). The Fmoc group serves as a protecting group that is introduced to prevent unwanted reactions at the amino group of L-alanine during the synthesis of peptides. The protection is reversible, allowing for selective deprotection, which is an essential step in the assembly of complex peptides.

1. Solid-Phase Peptide Synthesis (SPPS)
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-alanine丨CAS 35661-39-3 is predominantly used in the solid-phase peptide synthesis (SPPS) method, which is a widely used technique in peptide chemistry for synthesizing long-chain peptides. In SPPS, amino acids are attached sequentially to a solid support, with the Fmoc group protecting the amino group of each amino acid during synthesis.
● Protection of L-alanine: The Fmoc group effectively shields the amine group of L-alanine, preventing premature reactions during peptide elongation.
● Peptide assembly: The Fmoc group is selectively removed using a base, allowing the addition of subsequent amino acids.
● Versatile building block: Used for synthesizing peptides in fields such as drug development, biomolecular research, and therapeutic peptide production.
2. Synthesis of Therapeutic Peptides
Peptides with therapeutic potential, such as hormones, antimicrobial peptides, and neuropeptides, often require Fmoc-protected amino acids like Fmoc-L-alanine for their synthesis.
● Targeted therapy: Peptides synthesized with Fmoc-L-alanine can be used in targeted treatments, such as cancer immunotherapy or hormonal treatments.
● Custom peptides: Allows for precise control in the design of peptides with specific biological activities.
3. Peptide Libraries for Drug Discovery
Fmoc-L-alanine is an important building block in the preparation of peptide libraries for drug discovery. These libraries contain a wide variety of peptide sequences that can be screened for potential therapeutic effects.
● High-throughput screening: The peptides synthesized using Fmoc chemistry can be tested to identify promising candidates for treating diseases or as enzymatic inhibitors.
● Combinatorial chemistry: Facilitates the creation of large libraries of peptides for drug screening and biomolecule interactions.
4. Research in Protein-Protein Interactions
Peptides synthesized with Fmoc-L-alanine are often used to study protein-protein interactions, crucial for understanding cellular processes and developing new therapies.
● Molecular probes: These peptides can be used as molecular probes to interact with specific proteins and receptors, helping researchers understand disease mechanisms at the molecular level.
● In vitro studies: Facilitates studies on binding affinity, specificity, and the functional impact of specific peptide sequences on protein interactions.
5. Bioconjugation and Peptide-Drug Conjugates (PDCs)
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-alanine丨CAS 35661-39-3 plays a role in the synthesis of peptide-drug conjugates, a class of biopharmaceuticals that combine peptides with therapeutic agents to improve the selectivity and effectiveness of drugs.
● Targeted drug delivery: By attaching specific peptides to a drug, it allows for targeted delivery to specific tissues or cells, increasing the drug's efficacy and minimizing side effects.
● Cancer treatment: Peptide-drug conjugates have shown promise in the targeted treatment of cancer cells, where the peptide directs the drug specifically to tumor tissues.

1. Enhanced Control in Peptide Synthesis
The Fmoc protection group offers several advantages in peptide synthesis, particularly with regard to the efficiency and reproducibility of the process.
● Ease of deprotection: The Fmoc group can be easily removed using basic conditions (such as piperidine), which simplifies the process and improves yield during peptide assembly.
● Minimal side reactions: The Fmoc group is relatively stable and does not engage in unwanted side reactions, which allows for more precise control over the synthesis.
2. Higher Purity of Peptides
Peptides synthesized using Fmoc-L-alanine often have high purity due to the effective protection and selective removal of the Fmoc group.
● Reduced contamination: Fmoc-L-alanine ensures that the amino acid side chains do not react prematurely, resulting in cleaner peptide sequences.
● Better yields: The protection of the amino group during synthesis reduces the likelihood of peptide degradation, leading to better overall yields.
3. Versatility in Peptide Design
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-alanine丨CAS 35661-39-3 is highly versatile and can be used to create a wide range of peptides with varying sequence lengths and functional properties.
● Functionalization: The Fmoc protection allows the synthesis of peptides with modified side chains or bioactive groups, useful in drug design, enzyme inhibitors, or biomarker development.
● Tailored peptides: Researchers can create highly specific peptides for studying particular proteins or for developing specific therapeutic peptides for clinical applications.
4. Safe and Well-Established Technology
Fmoc-based chemistry is well-established in peptide synthesis and has a proven safety record for both laboratory and industrial use.
● Non-toxic reagents: The reagents used for Fmoc deprotection are generally non-toxic and safe to handle, making it ideal for both research and commercial-scale peptide production.
● Reliable protocol: The Fmoc synthesis method has been extensively optimized, providing reliable protocols for synthesizing peptides with consistent quality.
5. Compatibility with Automation
Fmoc-L-alanine-based peptide synthesis is easily compatible with automated peptide synthesizers, enabling the scaling up of peptide production for high-throughput applications.
● Increased efficiency: Automation significantly reduces manual labor, increases throughput, and enhances reproducibility in peptide production.
● Cost-effective: This scalability allows for the cost-effective synthesis of large peptide libraries or the industrial production of therapeutic peptides.

Conclusion
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-alanine丨CAS 35661-39-3, or Fmoc-L-alanine, is an essential building block in the field of peptide synthesis, particularly within solid-phase peptide synthesis (SPPS). Its applications span therapeutic peptide development, drug discovery, protein-protein interaction studies, and peptide-drug conjugates, playing a pivotal role in modern pharmaceutical and biotechnological research. The benefits of Fmoc protection, such as ease of deprotection, high peptide purity, and reproducibility, make it a preferred choice for researchers and manufacturers in peptide-related industries.